These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2685687)

  • 21. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of the ovarian cancer-associated antigen CA 125 in monitoring tumor burden and response to chemotherapy.
    Quaranta M; Coviello M; Donadeo A; Rella C; Lorusso V; Micelli G; Lucarelli C
    Tumori; 1991 Apr; 77(2):167-9. PubMed ID: 2048231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.
    Onetto M; Bruzzone M; Conte PF; Ruvolo M; Conio A; Chiara S; Falcone A; Bentivoglio G; Serra GE; Paganuzzi M
    Oncology; 1989; 46(2):117-22. PubMed ID: 2710476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
    Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
    [No Abstract]   [Full Text] [Related]  

  • 25. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
    Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
    Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
    Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
    Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
    Rose PG; Terrien JM; Baker S
    J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor markers of epithelial and stromal cell origin at second-look laparotomy in ovarian carcinoma.
    Tomás C; Kauppila A
    Gynecol Oncol; 1992 Jun; 45(3):279-83. PubMed ID: 1612504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of second-look laparotomy and cancer antigen 125 in the management of ovarian carcinoma.
    Selman AE; Copeland LJ
    Curr Oncol Rep; 1999 Sep; 1(1):71-6. PubMed ID: 11122801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive acidic protein and CA 125 levels in patients with ovarian cancer.
    Castelli M; Battaglia F; Scambia G; Panici PB; Ferrandina G; Mileo AM; Mancuso S; Ferrini U
    Oncology; 1991; 48(1):13-7. PubMed ID: 1987493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of CA 125 determination in the serum of patients with ovarian cancer].
    Bartel U; Johannsen B; Elling D
    Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum CA 125, CA 15.3 and CA 19.9 levels and surgical findings in patients undergoing second look operations for ovarian carcinomas.
    Barrenetxea G; Martin-Mateos M; Barzazan MJ; Montoya F; Matia JC; Rodriguez-Escudero FJ
    Eur J Gynaecol Oncol; 1990; 11(5):369-74. PubMed ID: 2097153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of serum 125Ca levels: does the result preclude second look?
    Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM
    Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer.
    Aravantinos D; Michalas S; Papazefkos V; Christoforaki M; Stypsaneli A; Vlachos G; Athanasiadis P
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):265-70. PubMed ID: 2227069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers in gynecologic diseases].
    Geyer H; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
    Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
    Gynecol Oncol; 1990 Sep; 38(3):373-6. PubMed ID: 2227551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor marker CA 125 in diagnosis, monitoring management and follow-up of patients with ovarian tumors.
    Vinokurov VL; Dudarev AL; Jurkova LE; Lapchenkov VI; Barbanel EJ
    Eur J Gynaecol Oncol; 1992; 13(2):205-8. PubMed ID: 1587297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation.
    Mogensen O; Mogensen B; Jakobsen A; Sell A
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1835-7. PubMed ID: 3220081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CA 15-3 serum levels in ovarian cancer.
    Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
    Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.